Atlas Trials

Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant

Clinical trial NCT05027906 · RECRUITING

Trial details

NCT number
NCT05027906
Sponsor
Eledon Pharmaceuticals
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prevention of Rejection in Kidney Transplant
Start date
2022-02-18
Primary completion
2027-01-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.